Surrozen SRZN
NASDAQ SRZN
$31.88 -0.76 (-2.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Surrozen (SRZN) Price to Sales (2023 - 2026)

Updated

Surrozen's (SRZN) Price to Sales stood at 26.50 in Q2 2026, up 336.5% from 6.07 a year earlier but down 40.7% from the prior quarter.

Analysis

Surrozen (SRZN) Price to Sales (2023 - 2026) Analysis & Trends

For FY2025, Surrozen's Price to Sales came in at 48.61.

  • Across earlier years, Price to Sales came in at 4.39 in FY2024 and 1.40 in FY2022.
  • Quarterly Price to Sales has ranged from 3.63 in Q1 2025 to 48.61 in Q4 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 44.66 (Q1 2026), 48.61 (Q4 2025) and 30.65 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Surrozen 384.30 Mn -14.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 35.99
Jun 30, 2026 26.50
Mar 31, 2026 44.66
Dec 31, 2025 48.61
Sep 30, 2025 30.65
Jun 30, 2025 6.07
Mar 31, 2025 3.63
Dec 31, 2024 4.39
Sep 30, 2024 3.89
Mar 31, 2024 2,364.36
Dec 31, 2023 969.61
API Access

Surrozen Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=SRZN&period=max&api_key=YOUR_API_KEY